A Philadelphia jury today awarded $2.5 million in the first of hundreds of product liability lawsuits nationwide that allege the antipsychotic drug Risperdal caused boys and young men to grow female-like breasts.
After testimony that lasted a month, the jury sided with the plaintiffs, the family of Austin Pledger, and against Janssen Pharmaceuticals Inc., a division of drug giant Johnson & Johnson.
The suit alleged that Pledger, after taking Risperdal over five years beginning in 2002, when he was 7, developed large breasts in an irreversible medical condition known as gynecomastia. Among other things, the plaintiffs alleged that the manufacturer failed to adequately warn of the risks of Risperdal, and that it worked for years to obscure evidence that the drug was linked to breast-tissue growth.
A second Risperdal trial started in Philadelphia last week, with more than 1,200 other cases waiting court dates.
Ross Feller Casey, a national leader in pharmaceutical lawsuits, is actively litigating nearly 200 Risperdal cases.
If you or a loved one has been injured after taking Risperdal, you should contact the experienced Risperdal lawyers at Ross Feller Casey immediately for a free case evaluation.
To learn more, go to www.rossfellercasey.com/practice-areas/gynecomastialawsuit/